Continuous infusion of β-lactams in the intensive care unit - Best way to hit the target?

Critical Care Medicine

Volumn 36, Issue 5, 2008, Pages 1663-1664

  Roberts, Jason A ^a   Paratz, Jennifer D ^a   Lipman, Jeffrey ^a  

^a NONE

Author keywords

Continuous infusion; Microdialysis; Pharmacodynamics; Therapeutic drug monitoring; lactam antibiotic

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CRITICAL ILLNESS; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG METABOLISM; DRUG MONITORING; DRUG PENETRATION; EDITORIAL; HUMAN; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; META ANALYSIS; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 42949119308     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181704625     Document Type: Editorial

References (16)

1. WA Craig Basic pharmacodynamics of antibacterials with clinical applications to the use of b-lactams, glycopeptides, and linezolid Infect Dis Clin N Am 17 2003 479 501
2. GL Drusano Antimicrobial pharmacodynamics: critical interactions of ‘bug and drug’ Nat Rev Microbiol 2 2004 289 300
3. JW Mouton JG den Hollander Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model Antimicrob Agents Chemother 38 1994 931 936
4. JA Roberts JD Paratz E Paratz Continuous infusion of beta-lactam antibiotics in severe infections - a review of its role Int J Antimicrob Agents 30 2007 11 18
5. SL Buijk IC Gyssens JW Mouton Pharmacokinetics of ceftazidime in serum and peritoneal exudate during continuous versus intermittent administration to patients with severe intra-abdominal infections J Antimicrob Chemother 49 2002 121 128
6. J Lipman CD Gomersall T Gin Continuous infusion ceftazidime in intensive care: a randomized controlled trial J Antimicrob Chemother 43 1999 309 311
7. DM Ryan Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans J Antimicrob Chemother 31 Suppl D 1993 1 16
8. MA Aarts JN Hancock D Heyland Empiric antibiotic therapy for suspected ventilator-associated pneumonia: A systematic review and meta-analysis of randomized trials Crit Care Med 36 2008 1500 1506
9. American Thoracic Society Infections Diseases Society of Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia Am J Respir Crit Care Med 171 2005 388 416
10. M Klompas Does this patient have ventilator-associated pneumonia? JAMA 297 2007 1583 1593
11. E Boselli D Breilh M Cannesson Steady-state plasma and intrapulmonary concentrations of piperacillin/tazobactam 4 g/0.5 g administered to critically ill patients with severe nosocomial pneumonia Intensive Care Med 30 2004 976 979
12. M Zeitlinger M Muller C Joukhadar Lung microdialysis–a powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review) AAPS 7 2005 E600 E608
13. JW Mouton U Theuretzbacher WA Craig Tissue concentrations: Do we ever learn? J Antimicrob Chemother 61 2007 235 237
14. S Kiem JJ Schentag Interpretation of antibiotic concentration ratios measured in epithelial lining fluid Antimicrob Agents Chemother 52 2008 24 36
15. P Liu R Fuhrherr AI Webb Tissue penetration of cefpodoxime into the skeletal muscle and lung in rats Eur J Pharm Sci 25 2005 439 444
16. J Lipman SC Wallis RJ Boots Cefepime versus cefpirome: the importance of creatinine clearance Anesth Analg 97 2003 1149 1154